AI Science Tracker
EN

Department of Pathology, Tongling People’s Hospital, China

2 discoveries from 2026

Discoveries

Machine learning-based prediction of lymph node metastasis in papillary thyroid carcinoma: an interpretable multidimensional model.

Source check: Source checked. Not independent scientific confirmation.

Finding: Interpretable machine learning using multidimensional clinical features predicted lymph-node metastasis in papillary thyroid carcinoma; the Results report validation in a retrospective cohort.

Technology: An interpretable machine-learning model used multidimensional clinical features to predict lymph-node metastasis in papillary thyroid carcinoma.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
An interpretable machine-learning model used multidimensional clinical features to predict lymph-node metastasis in papillary thyroid carcinoma.
Test and result
Interpretable machine learning using multidimensional clinical features predicted lymph-node metastasis in papillary thyroid carcinoma; the Results report validation in a retrospective cohort. Evaluation: Reported comparison, experimental confirmation or held-out evaluation was checked; reason limits interpretation to the evidence.
Limitation / still unknown
The result is based on retrospective cohort validation; prospective clinical utility and independent external validation are not established.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://doi.org/10.3389/fendo.2026.1866805

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Development and internal validation of a machine-learning model for 3-year mortality after lung cancer resection: an online risk calculator and nomogram.

Source check: Source checked. Not independent scientific confirmation.

Finding: For an outcome-ascertained sample of 350 lung-resection patients, a seven-model comparison estimated three-year mortality using a 70/30 internal holdout. Logistic regression was selected with validation AUC 0.79 (95% CI 0.70–0.87); random forest fell from training AUC 1.00 to validation AUC 0.73. The selected sample’s mortality proportion is not a population risk estimate, and external validation is absent.

Technology: A machine-learning model estimated three-year mortality after lung-cancer resection from cohort data and underwent internal validation.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
A machine-learning model estimated three-year mortality after lung-cancer resection from cohort data and underwent internal validation.
Test and result
The primary abstract reports LASSO feature selection followed by seven algorithms and a 70/30 internal split. In 350 outcome-ascertained patients, 166 had recorded death within 36 months; logistic regression achieved validation AUC 0.79 (95% CI 0.70–0.87), accuracy 0.75, F1 0.73 and Brier score 0.187. Random forest training AUC was 1.00 and validation AUC 0.73. The paper states the cohort event proportion must not be read as population mortality risk and that external validation is required.
Limitation / still unknown
The outcome-ascertained cohort and internal-only validation do not establish population-level absolute risk or prospective clinical utility; independent multicenter validation is required.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://doi.org/10.3389/fmed.2026.1815915

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.